Literature DB >> 17469160

Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis.

Consuelo M López de Padilla1, Abbe N Vallejo, Kelly T McNallan, Richard Vehe, Stephen A Smith, Allan B Dietz, Stanimir Vuk-Pavlovic, Ann M Reed.   

Abstract

OBJECTIVE: To examine whether dendritic cells (DCs) are constituents of muscle inflammation in juvenile dermatomyositis (DM).
METHODS: The types, numbers, and activation state of DC subsets in inflamed muscle tissue from patients with juvenile DM and in noninflamed muscle tissue from control subjects were examined by multicolor immunofluorescence. Chemokine expression of the muscle-infiltrating cells was examined by laser capture microdissection and quantitative polymerase chain reaction.
RESULTS: Plasmacytoid DCs were the predominant component of the inflamed muscle tissue from patients with juvenile DM. These cells were identified by coexpression of CD4 and CD123, but not CD11c, and also expressed CD83, indicating maturity of the cells. In contrast, in noninflamed muscle, plasmacytoid DCs were scarce and did not express CD83. Mononuclear cells surrounding the blood vessels of inflamed muscle contained abundant transcripts of CCL19 and CCL21, but very little CCL18 transcripts. In contrast, cells from noninflamed muscle contained negligible amounts of CCL19 and CCL21, but had high amounts of CCL18. Both the inflamed and noninflamed muscle tissue had equivalent levels of CXCL12 transcripts, but inflamed muscle contained more transcripts of the CXCL12 receptor CXCR4.
CONCLUSION: These findings are consistent with the idea that plasmacytoid DCs are mediators of muscle inflammation in juvenile DM. The abundance of CD83+ plasmacytoid DCs in perivascular areas and the overexpression of CCL19 and CCL21 in perivascular cellular foci suggest that in situ activation and maturation of resident plasmacytoid DCs are central to the initiation and perpetuation of muscle inflammation in juvenile DM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17469160     DOI: 10.1002/art.22558

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  40 in total

1.  Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells.

Authors:  Sheela Shrestha; Barry Wershil; John F Sarwark; Timothy B Niewold; Teresa Philipp; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2010-09

2.  Mast cells and type I interferon responses in the skin of patients with juvenile dermatomyositis: are current therapies just scratching the surface?

Authors:  Lisa G Rider; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2010-09

Review 3.  Gene-expression profiling in rheumatic disease: tools and therapeutic potential.

Authors:  Jason W Bauer; Hatice Bilgic; Emily C Baechler
Journal:  Nat Rev Rheumatol       Date:  2009-05       Impact factor: 20.543

4.  The inflammatory milieu in idiopathic inflammatory myositis.

Authors:  Ann M Reed; Floranne Ernste
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

5.  Juvenile dermatomyositis: new insights and new treatment strategies.

Authors:  Neil Martin; Charles K Li; Lucy R Wedderburn
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-02       Impact factor: 5.346

Review 6.  Immunotherapy of myositis: issues, concerns and future prospects.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Rheumatol       Date:  2010-02-02       Impact factor: 20.543

7.  Human plasmacytoid dendritic cell accumulation amplifies their type 1 interferon production.

Authors:  Anne P Liao; Mohammad Salajegheh; Chris Morehouse; Remedios Nazareno; Ronald G Jubin; Bahija Jallal; Yihong Yao; Steven A Greenberg
Journal:  Clin Immunol       Date:  2010-03-25       Impact factor: 3.969

Review 8.  Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.

Authors:  Angela B Robinson; Ann M Reed
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

9.  Preferential infiltration of interleukin-4-producing CXCR4+ T cells in the lesional muscle but not skin of patients with dermatomyositis.

Authors:  T Fujiyama; T Ito; N Ogawa; T Suda; Y Tokura; H Hashizume
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

10.  Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course.

Authors:  Ann M Reed; Erik Peterson; Hatice Bilgic; Steven R Ytterberg; Shreyasee Amin; Molly S Hein; Cynthia S Crowson; Floranne Ernste; Emily Baechler Gillespie
Journal:  Arthritis Rheum       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.